ProCE Banner Activity

Cytopenias and Myeloid Neoplasms After CAR T-Cell Therapies

Conference Coverage
Slideset

This slideset summarizes 2 retrospective studies presented at ASCO 2024 investigating patient and disease characteristics associated with the development of myeloid neoplasms and cytopenias after CAR T-cell therapies.

Released: June 06, 2024

Expiration: June 05, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from GSK, Lilly, Novartis Pharmaceuticals Corporation, and Sanofi.

GSK

Lilly

Novartis Pharmaceuticals Corporation

Sanofi